Associations between depression and cardiometabolic health: A 27-year longitudinal study. Issue 14 (12th October 2022)
- Record Type:
- Journal Article
- Title:
- Associations between depression and cardiometabolic health: A 27-year longitudinal study. Issue 14 (12th October 2022)
- Main Title:
- Associations between depression and cardiometabolic health: A 27-year longitudinal study
- Authors:
- Ditmars, Hillary L.
Logue, Mark W.
Toomey, Rosemary
McKenzie, Ruth E.
Franz, Carol E.
Panizzon, Matthew S.
Reynolds, Chandra A.
Cuthbert, Kristy N.
Vandiver, Richard
Gustavson, Daniel E.
Eglit, Graham M. L.
Elman, Jeremy A.
Sanderson-Cimino, Mark
Williams, McKenna E.
Andreassen, Ole A.
Dale, Anders M.
Eyler, Lisa T.
Fennema-Notestine, Christine
Gillespie, Nathan A.
Hauger, Richard L.
Jak, Amy J.
Neale, Michael C.
Tu, Xin M.
Whitsel, Nathan
Xian, Hong
Kremen, William S.
Lyons, Michael J. - Abstract:
- Abstract: Background: Clarifying the relationship between depression symptoms and cardiometabolic and related health could clarify risk factors and treatment targets. The objective of this study was to assess whether depression symptoms in midlife are associated with the subsequent onset of cardiometabolic health problems. Methods: The study sample comprised 787 male twin veterans with polygenic risk score data who participated in the Harvard Twin Study of Substance Abuse ('baseline') and the longitudinal Vietnam Era Twin Study of Aging ('follow-up'). Depression symptoms were assessed at baseline [mean age 41.42 years (s.d. = 2.34)] using the Diagnostic Interview Schedule, Version III, Revised. The onset of eight cardiometabolic conditions (atrial fibrillation, diabetes, erectile dysfunction, hypercholesterolemia, hypertension, myocardial infarction, sleep apnea, and stroke) was assessed via self-reported doctor diagnosis at follow-up [mean age 67.59 years (s.d. = 2.41)]. Results: Total depression symptoms were longitudinally associated with incident diabetes (OR 1.29, 95% CI 1.07–1.57), erectile dysfunction (OR 1.32, 95% CI 1.10–1.59), hypercholesterolemia (OR 1.26, 95% CI 1.04–1.53), and sleep apnea (OR 1.40, 95% CI 1.13–1.74) over 27 years after controlling for age, alcohol consumption, smoking, body mass index, C-reactive protein, and polygenic risk for specific health conditions. In sensitivity analyses that excluded somatic depression symptoms, only the associationAbstract: Background: Clarifying the relationship between depression symptoms and cardiometabolic and related health could clarify risk factors and treatment targets. The objective of this study was to assess whether depression symptoms in midlife are associated with the subsequent onset of cardiometabolic health problems. Methods: The study sample comprised 787 male twin veterans with polygenic risk score data who participated in the Harvard Twin Study of Substance Abuse ('baseline') and the longitudinal Vietnam Era Twin Study of Aging ('follow-up'). Depression symptoms were assessed at baseline [mean age 41.42 years (s.d. = 2.34)] using the Diagnostic Interview Schedule, Version III, Revised. The onset of eight cardiometabolic conditions (atrial fibrillation, diabetes, erectile dysfunction, hypercholesterolemia, hypertension, myocardial infarction, sleep apnea, and stroke) was assessed via self-reported doctor diagnosis at follow-up [mean age 67.59 years (s.d. = 2.41)]. Results: Total depression symptoms were longitudinally associated with incident diabetes (OR 1.29, 95% CI 1.07–1.57), erectile dysfunction (OR 1.32, 95% CI 1.10–1.59), hypercholesterolemia (OR 1.26, 95% CI 1.04–1.53), and sleep apnea (OR 1.40, 95% CI 1.13–1.74) over 27 years after controlling for age, alcohol consumption, smoking, body mass index, C-reactive protein, and polygenic risk for specific health conditions. In sensitivity analyses that excluded somatic depression symptoms, only the association with sleep apnea remained significant (OR 1.32, 95% CI 1.09–1.60). Conclusions: A history of depression symptoms by early midlife is associated with an elevated risk for subsequent development of several self-reported health conditions. When isolated, non-somatic depression symptoms are associated with incident self-reported sleep apnea. Depression symptom history may be a predictor or marker of cardiometabolic risk over decades. … (more)
- Is Part Of:
- Psychological medicine. Volume 52:Issue 14(2022)
- Journal:
- Psychological medicine
- Issue:
- Volume 52:Issue 14(2022)
- Issue Display:
- Volume 52, Issue 14 (2022)
- Year:
- 2022
- Volume:
- 52
- Issue:
- 14
- Issue Sort Value:
- 2022-0052-0014-0000
- Page Start:
- 3007
- Page End:
- 3017
- Publication Date:
- 2022-10-12
- Subjects:
- Depression -- Cardiometabolic health -- Polygenic risk scores
Psychiatry -- Periodicals
Medicine and psychology -- Periodicals
Clinical psychology -- Periodicals
616.89 - Journal URLs:
- http://journals.cambridge.org/action/displayJournal?jid=PSM ↗
- DOI:
- 10.1017/S003329172000505X ↗
- Languages:
- English
- ISSNs:
- 0033-2917
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library HMNTS - ELD Digital store
- Ingest File:
- 24379.xml